Preclinical CRO Longstanding preclinical CRO with GLP-compliant histology and tissue analysis capabilities, including immunohistochemistry and histomorphometry, supported by an on-site board-certified pathologist. Opportunity to upsell integrated imaging, biomarker validation, and GLP-compliant pathology services for drug development programs seeking comprehensive preclinical packages.

TCR Expertise Specialized tissue cross-reactivity testing aligned with FDA guidance, conducted under GLP, positioned to support monoclonal antibody and biologic programs requiring cross-reactivity assessment and safety evaluation during preclinical stages.

Midmarket Focus Company size and revenue indicate a mid-market CRO profile likely working with biotech and niche pharma clients. Potential sales focus on mid-sized biotech firms expanding preclinical capabilities, seeking cost-effective, fast-turnaround GLP services.

Digital & Tech Tech stack includes analytics and marketing tools (Snowplow, Google Tag Manager, HubSpot) suggesting a modern, digitally engaged outreach approach. Leverage digital channels to target researchers and procurement, offering streamlined engagement, quoting, and project management.

Strategic Growth Recent enhancements in tissue cross-reactivity and on-site pathology indicate capacity for expanded services and faster delivery timelines. Cross-sell opportunities exist across histology, IHC, plastics, and TCR testing to broaden the service portfolio for ongoing drug discovery programs.